Micrus Endovascular to Hold Fiscal 2010 Second Quarter Conference Call on November 5

SAN JOSE, Calif.--(Business Wire)--
Micrus Endovascular Corporation (Nasdaq: MEND) today announced that it will
release financial results for the quarter ended September 30, 2009 before market
open on Thursday, November 5, 2009. Micrus` management will host an investment
community conference call at 10:30 a.m. Eastern time (7:30 a.m. Pacific time) to
discuss those results and answer questions.

Individuals interested in participating in the conference call may do so by
dialing (888) 803-8296 for domestic callers, or (706) 679-0753 for international
callers. Those interested in listening to the conference call live via the
Internet may do so by visiting the Investor Relations section of the company`s
Web site at www.micruscorp.com.

A telephone replay will be available for 48 hours following the conclusion of
the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for
international callers, and entering reservation code 32806729.

A webcast replay will be available for 30 days by visiting the Investor
Relations section on the Micrus Web site.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical
devices for use in the treatment of cerebral vascular diseases. Micrus products
are used by interventional neuroradiologists, interventional neurologists and
neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic
stroke and intracranial atherosclerosis, which may lead to ischemic stroke.
Hemorrhagic and ischemic stroke are both significant causes of death and
disability worldwide. The Micrus product lines enable physicians to gain access
to the brain in a minimally invasive manner through the vessels of the arterial
system. Micrus` proprietary, three-dimensional microcoils anatomically deploy
within the aneurysm, forming a scaffold that conforms to a wide diversity of
aneurysm shapes and sizes. Micrus also sells stents, balloon catheters, access
devices such as guide catheters, microcatheters, guidewires and accessory
products used in conjunction with its microcoils. For more information, visit
www.micruscorp.com.

Company Contact:
Micrus Endovascular Corporation
Gordon Sangster (gsangster@MicrusCorp.com)
Chief Financial Officer
(408) 433-1400
or
Investor Contact:
Lippert/Heilshorn & Associates, Inc.
Jody Cain (jcain@lhai.com)
Bruce Voss (bvoss@lhai.com)
(310) 691-7100

Copyright Business Wire 2009